Clinical Trial Update: Phase III Trial of Febuxostat in Korea Gout Patients [Phase 3]

View source ↗

Summary

Phase 3 trial of febuxostat in Korean gout patients has completed. The snippet does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Gout | Phase 3 | Status: COMPLETED